May 19, 2020
Teva Canada Secures Salbutamol Inhalers from its Global Supply Chain to Mitigate Shortage in Canadian Market
Apr 30, 2020
Switching Patterns Among Relapsing-Remitting Multiple Sclerosis: Genentech's Ocrevus on the Rise, Biogen's Tecfidera Declines, and Teva's Copaxone Remains Strong, According to Spherix Global Insights
Jan 06, 2020
Teva Pharmaceuticals Agrees To Pay $54 Million To Settle Shepherd, Finkelman, Miller & Shah, LLP False Claims Act Qui Tam Case
Dec 18, 2019
Amgen/Novartis' Aimovig Label Revision and Teva's Ajovy Autoinjector Delay Clear the Way for Continued Growth of Eli Lilly's Emgality in the US Migraine Prevention Market, According to Spherix Global Insights
Sep 26, 2019
Strong Uptake in the Expanding Preventive-Treated Episodic Migraine Segment Has Propelled Eli Lilly's Third-to-Market Emgality to Second Place in the Anti-CGRP Class Surpassing Teva's Ajovy
Sep 13, 2019
INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals
Sep 11, 2019
Unimpeded by Allergan's Botox Dominance, Amgen/Novartis' Aimovig, Teva's Ajovy, and Eli Lilly's Emgality Use at the Patient Level is More Robust Within the Episodic Migraine Segment Than Physicians Are Aware of
Aug 20, 2019
SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders of Class Action and Lead Plaintiff Deadline: August 20, 2019
Jul 12, 2019
Global Treanda (bendamustine; Teva/Mundipharma/Eisai Drug Overview & Product Profiles 2017-2026
Mar 25, 2019
Spherix Global Insights' Quarterly Update on the US Migraine Prevention Market Reveals Best-In-Class Sales and Medical Affairs Support as the Driving Force Behind Teva's Ajovy Early Launch Success
Feb 21, 2019
Trimb Enters into Exclusive Licensing Agreement with Teva for Flux, Decubal and Other Brands
Oct 09, 2018
Uptake of Biogen's Tecfidera and Increased Availability of Merck KGaA's Mavenclad Fueling Significant Increase in Oral Disease-Modifying Therapy Share of Multiple Sclerosis Patients in Europe to the Detriment of Teva's Copaxone
Feb 08, 2018
Indivior Files Complaints Asserting New SUBOXONE® Film Patent Against ANDA-filers
Dec 17, 2017
Strike over Teva layoffs briefly halts flights at Israel's main airport
Dec 17, 2017
Strike over Teva cuts briefly halts flights at Israel's main airport
Dec 17, 2017
Strike stops flights at Israel's main airport
Dec 17, 2017
Strike stops flights Israel's main airport
Dec 15, 2017
Israel strike to stop flights at Ben Gurion airport
Dec 11, 2017
Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone® 40 mg/mL
Oct 19, 2017
New Belief-based Patient Support Programme (PSP) Launched for People With Relapsing Multiple Sclerosis